Paul Beastall
Paul is the nominated Director for Innovate UK on the Board of Medicines Discovery Catapult and was appointed in 2022. He is an engineer who has spent his career working at the interface between technical innovation and successful business, working with organisations from multinational corporations to venture-funded start-ups. Prior to moving to build a portfolio career, […]
Professor Chris Molloy
Professor Chris Molloy has a 30-year international board and executive career across a unique range of life sciences R&D disciplines. His career began in preclinical research at Glaxo, where he was closely involved with the industrialisation of high throughput discovery. In 2004 he moved to Asia as COO of MerLion Pharmaceuticals, a Singaporean biotech that […]
Robert Sherville-Payne
With a professional legal and compliance background and over 25 years of commercial experience, Robert brings significant expertise as a solicitor to his role as General Counsel and Company Secretary at Medicines Discovery Catapult. Having trained and worked at law firm Hogan Lovells in London, Robert spent 14 years at AstraZeneca in a range of […]
Sue Wallcraft
Sue is a qualified English solicitor and has over 25 years’ experience of advising life sciences companies and charities. Most recently Sue was General Counsel and Company secretary at Vernalis plc, having previously held the same positions at the Wellcome Trust. Sue’s career also includes holding the position of Assistant General Counsel for Pfizer’s primary […]
Alistair Macdonald
Alistair is Chief Executive Officer at Syneos Health and has over 20 years experience in the biopharmaceutical industry. He currently serves as the Chair of the Association of Clinical Research Organisations. Prior to Syneos Health, he served as CEO of INC Research since 2016, leading global operations, driving the company’s global expansion, overall project delivery […]
Graham Clarke
Graham holds a number of non-executive positions including: Non-Executive member of the Department of Health and Social Care (“DHSC”), sitting on its Audit & Risk Committee. Non-Executive Director of the NHS Health Research Authority (“HRA”), the regulator of human research in England and Wales. Chairman of the board at Herts Urgent Care, a Social Enterprise […]
Lynne Robb
Lynne began her career as a Chartered Accountant when she trained with Arthur Andersen & Co in London and Leeds. She then moved into the corporate world, working for many years with Tate & Lyle, where she had several Financial leadership roles. She also worked on major integrations and mergers, which led her to join […]
Dr Robin Brown
Robin was appointed Chairman of the Medicines Discovery Catapult in July 2018. Most recently he was the Chief Executive Officer of KWS BioTest, a specialist immunology-based contract research organisation. In January 2018 KWS was acquired by Charles River Laboratories. Immediately before joining KWS, Robin spent eight years as a venture partner at Advent Healthcare Ventures […]
Professor Chris Reilly
Chris is an expert on the discovery and early clinical development of new medicines. He was formerly Global Vice President and Head of Project Evaluation at AstraZeneca (AZ) where he made investment recommendations on all lead identification and optimisation projects across all research areas. Chris was also responsible for developing AZ’s research strategy and was […]